User login
The ASHG has issued a statement for families, clinicians, and investigators on the ethical, legal, and social issues concerning genetic testing in children. Points to consider are offered on a broad range of test technologies and their applications in clinical medicine and research, including predictive testing for high-risk families, genome sequencing, carrier testing, direct-to-consumer testing, pharmacogenomics testing, and newborn screening. Recommendations are also made for communication and recording of results and education of healthcare providers.
The ASHG has issued a statement for families, clinicians, and investigators on the ethical, legal, and social issues concerning genetic testing in children. Points to consider are offered on a broad range of test technologies and their applications in clinical medicine and research, including predictive testing for high-risk families, genome sequencing, carrier testing, direct-to-consumer testing, pharmacogenomics testing, and newborn screening. Recommendations are also made for communication and recording of results and education of healthcare providers.
The ASHG has issued a statement for families, clinicians, and investigators on the ethical, legal, and social issues concerning genetic testing in children. Points to consider are offered on a broad range of test technologies and their applications in clinical medicine and research, including predictive testing for high-risk families, genome sequencing, carrier testing, direct-to-consumer testing, pharmacogenomics testing, and newborn screening. Recommendations are also made for communication and recording of results and education of healthcare providers.
